PFE
Reserved
Reserved
Pfizer -5,2%: nuovo segnale di vendita, ma aprire uno short resta sconsigliato
EXECUTIVE VIEW
Le azioni Pfizer cedono il 5,2% nella settimana e fanno scattare un nuovo segnale di vendita. Per il nostro modello aprire uno short resta sconsigliato: vendere allo scoperto seguendo il segnale ha chiuso in media in perdita.
Reserved analysis
Subscribe to read →
Pfizer -5.2%: a new sell signal fires, but our model advises against shorting
EXECUTIVE VIEW
Pfizer stock drops 5.2% this week and triggers a new sell signal. Our model still advises against opening a short: historically, short selling on the signal has lost money on average, as shares tend to rise over time.
Reserved analysis
Subscribe to read →